ArticleExperimental and therapeutic medicine2017

A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus.

Huibiao Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.